Despite having only received a $700k government grant to build a much needed viral vaccine facility, Apiam Animal Health (ASX: AHX) is already eyeing production within the next 12 months, potentially including one for Japanese Encephalitis which is currently impacting the Australian’s pig industry. While the state-of-the-art facility is not expected to be fully completed
Read More
Following the successful strategy employed in Queensland with their dedicated equine hub and support clinics, Apiam Animal Health (ASX: AHX) has set fresh foundations for growth in New South Wales with the acquisition of Agnes Banks Equine Clinic which will form the cornerstone of their operations in the State. Already Australia’s largest provider of regional
Read More
The US Environmental Protection Agency has granted regulatory label approval for the commercialisation of Xtend 21®– an innovative product that has been demonstrated by university studies to enhance long term antimicrobial surface protection. The pathway of Xtend 21® for the US market first commenced in March 2020 when Apiam Animal Health (ASX: AHX) was appointed the exclusive
Read More
Expanding their network into a major agricultural centre, Apiam Animal Health (ASX: AHX) has acquired a major veterinary business in Dubbo – a central farming and equine region in New South Wales. The region in particular is one of the fastest growing in New South Wales with a current population of 40,000. The local economy
Read More